FindTrial
Sign In

Clopidogrel+aspirin

DRUG2 trials

Sponsors

Seoul National University Hospital, Shenyang Northern Hospital

Conditions

Influence of Aspirin on the Pharmacokinetics/Pharmacodynamics of ClopidogrelInfluence of Genotype of Drug Metabolizing Enzyme or Transporter on the Pharmacokinetics/Pharmacodynamics of ClopidogrelProlonged DAPT in ACS Patients With Hisk of Both Ischemic and Hemorrhage

Phase 4

Clinical Trial to Evaluate the Influence of Genotype on the Pharmacokinetics/Pharmacodynamics of Clopidogrel
CompletedNCT01503658
Seoul National University HospitalInfluence of Aspirin on the Pharmacokinetics/Pharmacodynamics of Clopidogrel, Influence of Genotype of Drug Metabolizing Enzyme or Transporter on the Pharmacokinetics/Pharmacodynamics of Clopidogrel
Start: 2012-01-31End: 2012-05-31Updated: 2012-06-19
Optimal antiPlatelet Therapy for High Bleeding and Ischemic RISK Patients Trial
CompletedNCT03431142
Shenyang Northern HospitalProlonged DAPT in ACS Patients With Hisk of Both Ischemic and Hemorrhage
Start: 2018-02-12End: 2020-12-30Updated: 2025-08-21

Related Papers

Clopidogrel Versus Dual‐Antiplatelet Therapy for Long‐Term Maintenance After Coronary Stenting in Ischemic and Bleeding Birisk Patients With Acute Coronary Syndromes and Diabetes: A Prespecified Subgroup Analysis of the OPT‐BIRISK Trial
Journal of the American Heart Association2026-08-20
Extended Clopidogrel Monotherapy vs DAPT in Patients With Acute Coronary Syndromes at High Ischemic and Bleeding Risk: The OPT-BIRISK Randomized Clinical Trial.
2024-06-0123 citations